國立高雄大學圖資館 |

Language: English

Back

High density lipoproteinsfrom biolog...

Eckardstein, Arnold von.

High density lipoproteinsfrom biological understanding to clinical exploitation /

Record Type:	Electronic resources : Monograph/item
Title/Author:	High density lipoproteinsedited by Arnold von Eckardstein, Dimitris Kardassis.
Reminder of title:	from biological understanding to clinical exploitation /
other author:	Eckardstein, Arnold von.
Published:	Cham :Springer International Publishing :2015.
Description:	xiii, 694 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
Subject:	High density lipoproteins.
Online resource:	http://dx.doi.org/10.1007/978-3-319-09665-0
ISBN:	9783319096650 (electronic bk.)

High density lipoproteinsfrom biological understanding to clinical exploitation /
High density lipoproteinsfrom biological understanding to clinical exploitation /[electronic resource] :edited by Arnold von Eckardstein, Dimitris Kardassis. - Cham :Springer International Publishing :2015. - xiii, 694 p. :ill. (some col.), digital ;24 cm. - Handbook of experimental pharmacology,v.2240171-2004 ;. - Handbook of experimental pharmacology ;208..

Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.

In this Handbook of Experimental Pharmacology on High Density Lipoproteins from biological understanding to clinical exploitation contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.

ISBN: 9783319096650 (electronic bk.)

Standard No.: 10.1007/978-3-319-09665-0doiSubjects--Topical Terms:

486208
High density lipoproteins.

LC Class. No.: QP99.3.H53

Dewey Class. No.: 572.68

High density lipoproteinsfrom biological understanding to clinical exploitation /
LDR:01999nmm a2200325 a 4500 001 460947
003 DE-He213
005 20150729151426.0
006 m d
007 cr nn 008maaau
008 151110s2015 gw s 0 eng d
020 $a 9783319096650 (electronic bk.)
020 $a 9783319096643 (paper)
024 7 $a 10.1007/978-3-319-09665-0 $2 doi
035 $a 978-3-319-09665-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QP99.3.H53
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 572.68 $2 23
090 $a QP99.3.H53 $b H638 2015
245 0 0 $a High density lipoproteins $h [electronic resource] : $b from biological understanding to clinical exploitation / $c edited by Arnold von Eckardstein, Dimitris Kardassis.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xiii, 694 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.224
505 0 $a Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
520 $a In this Handbook of Experimental Pharmacology on High Density Lipoproteins from biological understanding to clinical exploitation contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.
650 0 $a High density lipoproteins. $3 486208
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Molecular Medicine. $3 273932
650 2 4 $a Human Physiology. $3 274509
650 2 4 $a Immunology. $3 189152
650 2 4 $a Cell Biology. $3 274165
700 1 $a Eckardstein, Arnold von. $3 712739
700 1 $a Kardassis, Dimitris. $3 712740
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-09665-0
950 $a Biomedical and Life Sciences (Springer-11642)